Nevertheless, mutated NPM1 appears to herald a particularly aggressive course and deserves AML-like management.7 Both classifications acknowledge the role of immunophenotyping in differentiating CMML from other causes of monocytosis without clonality. This evidence concerns the gene NPM1 and chronic myelomonocytic leukemia.